| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| CXCR5 Modified EGFR Chimeric Antigen Receptor Autologous T Cell Therapy | Phase 1 Clinical | Second Affiliated Hospital Of Guangzhou Medical University | Carcinoma, Non-Small-Cell Lung | Details |